The role of the PLA2G6 gene in neurodegenerative diseases

Ageing Res Rev. 2023 Aug:89:101957. doi: 10.1016/j.arr.2023.101957. Epub 2023 May 24.

Abstract

PLA2G6-associated neurodegeneration (PLAN) represents a continuum of clinically and genetically heterogeneous neurodegenerative disorders with overlapping features. Usually, it encompasses three autosomal recessive diseases, including infantile neuroaxonal dystrophy or neurodegeneration with brain iron accumulation (NBIA) 2A, atypical neuronal dystrophy with childhood-onset or NBIA2B, and adult-onset dystonia-parkinsonism form named PARK14, and possibly a certain subtype of hereditary spastic paraplegia. PLAN is caused by variants in the phospholipase A2 group VI gene (PLA2G6), which encodes an enzyme involved in membrane homeostasis, signal transduction, mitochondrial dysfunction, and α-synuclein aggregation. In this review, we discuss PLA2G6 gene structure and protein, functional findings, genetic deficiency models, various PLAN disease phenotypes, and study strategies in the future. Our primary aim is to provide an overview of genotype-phenotype correlations of PLAN subtypes and speculate on the role of PLA2G6 in potential mechanisms underlying these conditions.

Keywords: Genetics; Neuroaxonal dystrophy; Neurodegeneration with brain iron accumulation; Neurodegenerative disorders; PLA2G6 gene; Parkinsonism.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genetic Association Studies
  • Group VI Phospholipases A2 / genetics
  • Humans
  • Mutation
  • Neuroaxonal Dystrophies* / genetics
  • Neurodegenerative Diseases* / genetics
  • Parkinsonian Disorders* / genetics

Substances

  • PLA2G6 protein, human
  • Group VI Phospholipases A2

Supplementary concepts

  • Dystonia-Parkinsonism, Adult-Onset